[{"indications": "Indications\u00a0non-infected inflammatory\r\nconditions of nose", "name": "BETAMETHASONE SODIUM PHOSPHATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "12 Ear, nose, and oropharynx", "12.2 Drugs acting on the nose", "12.2.1 Drugs used in nasal allergy", "Corticosteroids", "BETAMETHASONE SODIUM PHOSPHATE"], "cautions": "Cautions\u00a0\n(From Corticosteroids: British National Formulary)\nCautions\u00a0Corticosteroid nasal preparations should be avoided in the presence of untreated nasal infections, and also after nasal surgery (until healing has occurred); they should also be avoided in pulmonary tuberculosis. Patients transferred from systemic corticosteroids may experience exacerbation of some symptoms. Systemic absorption may follow nasal administration particularly if high doses are used or if treatment is prolonged; for cautions and side-effects of systemic corticosteroids, see section 6.3.2. The risk of systemic effects may be greater with nasal drops than with nasal sprays; drops are administered incorrectly more often than sprays. The height of children receiving prolonged treatment with nasal corticosteroids should be monitored; if growth is slowed, referral to a paediatrician should be considered.", "side-effects": "Side-effects\u00a0\n(From Corticosteroids: British National Formulary)\nSide-effects\u00a0Local side-effects include dryness, irritation of nose and throat, and epistaxis. Nasal ulceration has been reported, but occurs commonly with nasal preparations containing fluticasone furoate or mometasone furoate. Nasal septal perforation (usually following nasal surgery) occurs very rarely. Raised intra-ocular pressure or glaucoma may occur rarely. Headache, smell and taste disturbances may also occur. Hyperactivity, sleep disturbances, anxiety, depression, and aggression have been reported particularly in children. Hypersensitivity reactions, including bronchospasm, have been reported.", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5646.htm", "doses": ["nose, 2\u20133 drops into each nostril twice\r\ndaily; ear, section\r\n12.1.1; eye, section 11.4.1"]}, {"indications": "Indications\u00a0eczematous inflammation in otitis\r\nexterna (\n(From 12.1.1 Otitis externa: British National Formulary)\n12.1.1 Otitis externa)", "name": "BETAMETHASONE SODIUM PHOSPHATE - ANTI-INFLAMMATORY PREPARATIONS", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "12 Ear, nose, and oropharynx", "12.1 Drugs acting on the ear", "12.1.1 Otitis externa", "Anti-inflammatory preparations", "Corticosteroids", "BETAMETHASONE SODIUM PHOSPHATE"], "cautions": "Cautions\u00a0\n(From Corticosteroids: British National Formulary)\nCautions\u00a0Prolonged use of topical corticosteroid ear preparations should be avoided.", "side-effects": "Side-effects\u00a0\n(From Corticosteroids: British National Formulary)\nSide-effects\u00a0Local sensitivity reactions may occur.", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/31393.htm", "doses": ["ear, apply 2\u20133 drops every 2\u20133 hours; reduce\r\nfrequency when relief obtained; eye, section 11.4.1; nose, section 12.2.1"]}, {"indications": "Indications\u00a0non-infected inflammatory\r\nconditions of nose", "name": "BETAMETHASONE SODIUM PHOSPHATE - DRUGS USED IN NASAL ALLERGY", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "12 Ear, nose, and oropharynx", "12.2 Drugs acting on the nose", "12.2.1 Drugs used in nasal allergy", "Corticosteroids", "BETAMETHASONE SODIUM PHOSPHATE"], "cautions": "Cautions\u00a0\n(From Corticosteroids: British National Formulary)\nCautions\u00a0Corticosteroid nasal preparations should be avoided in the presence of untreated nasal infections, and also after nasal surgery (until healing has occurred); they should also be avoided in pulmonary tuberculosis. Patients transferred from systemic corticosteroids may experience exacerbation of some symptoms. Systemic absorption may follow nasal administration particularly if high doses are used or if treatment is prolonged; for cautions and side-effects of systemic corticosteroids, see section 6.3.2. The risk of systemic effects may be greater with nasal drops than with nasal sprays; drops are administered incorrectly more often than sprays. The height of children receiving prolonged treatment with nasal corticosteroids should be monitored; if growth is slowed, referral to a paediatrician should be considered.", "side-effects": "Side-effects\u00a0\n(From Corticosteroids: British National Formulary)\nSide-effects\u00a0Local side-effects include dryness, irritation of nose and throat, and epistaxis. Nasal ulceration has been reported, but occurs commonly with nasal preparations containing fluticasone furoate or mometasone furoate. Nasal septal perforation (usually following nasal surgery) occurs very rarely. Raised intra-ocular pressure or glaucoma may occur rarely. Headache, smell and taste disturbances may also occur. Hyperactivity, sleep disturbances, anxiety, depression, and aggression have been reported particularly in children. Hypersensitivity reactions, including bronchospasm, have been reported.", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/5645.htm", "doses": ["nose, 2\u20133 drops into each nostril 2\u20133 times\r\ndaily; ear, section\r\n12.1.1; eye, section 11.4.1"]}, {"indications": "Indications\u00a0eczematous inflammation in otitis\r\nexterna (\n(From 12.1.1 Otitis externa: British National Formulary)\n12.1.1 Otitis externa)", "name": "BETAMETHASONE SODIUM PHOSPHATE With antibacterial", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "12 Ear, nose, and oropharynx", "12.1 Drugs acting on the ear", "12.1.1 Otitis externa", "Anti-inflammatory preparations", "Corticosteroids", "BETAMETHASONE SODIUM PHOSPHATE", "With antibacterial"], "cautions": "Cautions\u00a0\n(From Corticosteroids: British National Formulary)\nCautions\u00a0Prolonged use of topical corticosteroid ear preparations should be avoided.", "side-effects": "Side-effects\u00a0\n(From Corticosteroids: British National Formulary)\nSide-effects\u00a0Local sensitivity reactions may occur.", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/31395.htm", "doses": ["Name[Betnesol-N\u00ae (UCB Pharma) ] Drops (for ear, eye, or nose), betamethasone sodium phosphate 0.1%, neomycin\r\nsulphate 0.5%. Net price 10\u00a0mL = \u00a32.39Excipients  include benzalkonium chloride, disodium edetateDose\u00a0ear, apply 2\u20133 drops 3\u20134 times daily; eye, section 11.4.1; nose, section 12.2.3"]}]